In 1976, he graduated from the Novosibirsk State Medical Institute with honors. In 1993, he completed advanced training at a private neurosurgical clinic in Tulsa (USA). In 1994, he completed an advanced training course on ultrasound methods for studying cerebral circulation in Munster (Germany). From 1995 to 1997, he worked as a Senior Resident Neurosurgeon in the Department of Neuroscience at Queen's Medical Center, Nottingham, England.
In February 1997, he completed an advanced course in neurosurgery at the Royal London Hospital. On September 1-2, 1997 in Birmingham Alexey Leonidovich Krivoshapkin successfully passed the Inter-Collegiate Exam in neurosurgery (the highest level exam) and was recognized as a specialist neurosurgeon by four royal colleges of the United Kingdom of Great Britain and Northern Ireland. Entered by the General Medical Council in the Register of Specialists of Great Britain. In 1998, he was elected a Fellow of the Royal College of Surgeons of England.
A. L. Krivoshapkin's research is devoted to the development of the most important sections of neurosurgery, the introduction of high-tech interventions on the structures of the brain and its vessels. He developed and patented technologies for microsurgical treatment of arteriovenous malformations of the brain. Original methods for the treatment of cerebral angiospasm that develops with spontaneous subarachnoid hemorrhage are proposed.
A method for differential diagnosis of brain edema types in neurosurgical patients has been developed. The technology of endovascular treatment of ruptured arterial aneurysms of the brain in conditions of cerebral vasospasm, approved by the Federal Service for Supervision of Health and Social Development, has significantly reduced patient mortality.
For the first time in the Siberian region, A. L. Krivoshapkin began to use neuron navigation technologies when performing operations on brain structures. He proved the effectiveness of their use for radical removal of malignant brain tumors.
Together with scientists from the Institute of Catalysis of the Siberian Branch of the Russian Academy of Sciences, he created a domestic biological glue Sulfacrylate, which is successfully used in various fields of neurosurgery. The technology of endovascular embolization of arteriovenous malformations and vascular brain tumors has been developed.
